Łoboda, Chamberlain, and Dulak review genetic strategies for Duchenne muscular dystrophy, focusing on exon skipping, gene replacement, and CRISPR-Cas9 editing to restore dystrophin or upregulate utrophin. Here, UTRN is linked to Duchenne muscular dystrophy.